Alembic given FDA green light for generic Anafranil
Clomipramine hydrochloride capsules are indicated for the treatment of obsessions and compulsions in patients with OCD.
The Food and Drug Administration has given permission to Alembic for clomipramine hydrochloride capsules in dosage strengths of 25 mg, 50 mg and 75 mg.
The product is the generic of SpecGX’s Anafranil capsules.
The medication is indicated for the treatment of obsessions and compulsions in patients with OCD.
Clomipramine hydrochloride capsules have an estimated market size of $32 million for the 12 months ending June 2021, according to IQVIA data.